🇺🇸 FDA
Patent

US 8722884

Pyrimidine derivatives for the treatment of abnormal cell growth

granted A61PA61P1/02A61P13/08

Quick answer

US patent 8722884 (Pyrimidine derivatives for the treatment of abnormal cell growth) held by VERASTEM, INC. expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VERASTEM, INC.
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/02, A61P13/08, A61P13/10, A61P19/08